- Home
- FLNT vs ONCY Comparison
FLNT vs ONCY Comparison
Compare FLNT & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FLNT | ONCY |
|---|---|---|
| Founded | 2010 | 1998 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Advertising | Pharmaceuticals and Biotechnology |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 108.5M | 94.0M |
| IPO Year | 2009 | 2002 |
Fundamental Metrics
Financial Performance| Metric | FLNT | ONCY |
|---|---|---|
| Price | $3.48 | $1.06 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | $3.50 | ★ $7.33 |
| AVG Volume (30 Days) | 29.5K | ★ 885.3K |
| Earning Date | 05-14-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 41.67 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $208,764,000.00 | N/A |
| Revenue This Year | $5.89 | N/A |
| Revenue Next Year | $12.62 | $2,505.00 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.50 | $0.33 |
| 52 Week High | $4.15 | $1.51 |
Technical Indicators
Market Signals| Indicator | FLNT | ONCY |
|---|---|---|
| Relative Strength Index (RSI) | 54.24 | 56.88 |
| Support Level | $2.93 | $0.94 |
| Resistance Level | $3.57 | $1.13 |
| Average True Range (ATR) | 0.23 | 0.09 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 79.83 | 87.53 |
Price Performance
Historical ComparisonAbout FLNT Fluent Inc.
Fluent Inc is a data-driven digital marketing services company. It performs customer acquisition services by operating digital marketing campaigns, through which it connects its advertiser clients with consumers company is seeking to reach. It delivers data and performance-based marketing executions to its clients, such as consumer brands, direct marketers and agencies across a wide range of industries, including Financial Products & Services, Media & Entertainment, Health & Wellness, Staffing & Recruitment and Retail & Consumer.
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.